Exelixis (EXEL) Tops Q1 EPS by 25c, provides guidance
Tweet
Share
E-mailGet Alerts EXEL Hot Sheet
Price: $54.64 --0%
Revenue Growth %: +8.8%
Financial Fact:
Restructuring charge: 1.02M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Revenue Growth %: +8.8%
Financial Fact:
Restructuring charge: 1.02M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Exelixis (NASDAQ: EXEL) reported Q1 EPS of $0.62, $0.25 better than the analyst estimate of $0.37. Revenue for the quarter came in at $555.4 million versus the consensus estimate of $495.3 million.
GUIDANCE:
Exelixis sees FY2025 revenue of $2.25-2.35 billion, versus the consensus of $2.252 billion.
For earnings history and earnings-related data on Exelixis (EXEL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic jumps on earnings beat and raised guidance
- Science Applications Int'l (SAIC) Tops Q2 EPS by 70c
- IMAX Corporation (IMAX) Reiterated at Buy by StoneX: Potential for Upside to Q3 Estimates
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
